000			01956 a2200529 4500
005			20250517120511.0
264		0	_c20171204
008			201712s 0 0 eng d
022			_a1421-9786
024	7		_a10.1159/000450926 _2doi
040			_aNLM _beng _cNLM
100	1		_aWestendorp, Willeke F
245	0	0	_aPre-Stroke Use of Beta-Blockers Does Not Lower Post-Stroke Infection Rate: An Exploratory Analysis of the Preventive Antibiotics in Stroke Study. _h[electronic resource]
260			_bCerebrovascular diseases (Basel, Switzerland) _c2016
300			_a506-511 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic beta-Antagonists _xadverse effects
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aAntibiotic Prophylaxis _xadverse effects
650	0	4	_aBacterial Infections _xdiagnosis
650	0	4	_aCeftriaxone _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aOdds Ratio
650	0	4	_aOpportunistic Infections _xdiagnosis
650	0	4	_aPneumonia, Bacterial _ximmunology
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aStroke _xcomplications
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUrinary Tract Infections _ximmunology
700	1		_aVermeij, Jan-Dirk
700	1		_aBrouwer, Matthijs C
700	1		_aRoos, Y B W E M
700	1		_aNederkoorn, Paul J
700	1		_avan de Beek, Diederik
773	0		_tCerebrovascular diseases (Basel, Switzerland) _gvol. 42 _gno. 5-6 _gp. 506-511
856	4	0	_uhttps://doi.org/10.1159/000450926 _zAvailable from publisher's website
999			_c26482117 _d26482117